Back to search

Article

CRISPR-Cas9-Mediated Construction of a Streptococcus agalactiae Vaccine for Tilapia and Evaluation of Its Protective Efficacy

2026-04-09

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Streptococcus agalactiae (GBS) causes severe tilapia streptococcosis with heavy aquaculture losses; existing vaccines have administration or efficacy limitations. This study used CRISPR-Cas9 to construct recombinant E. coli DH5α-ORF4-GFP (targeting GBS ScpB gene ORF4 fragment), optimized tilapia immersion immunization doses/frequencies, and evaluated the vacci...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba4cd89e-7b68-5e2e-b15b-eac880139002
DOI
10.21203/rs.3.rs-9209433/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-Cas9-Mediated Construction of a Streptococcus agalactiae Vaccine for Tilapia and Evaluation of Its Protective EfficacyDOI 10.21203/rs.3.rs-9209433/v1
Select a neighboring publication to make it the new centre.